Orally active insulin mimics: where do we stand now?

@article{Balasubramanyam2001OrallyAI,
  title={Orally active insulin mimics: where do we stand now?},
  author={Muthuswamy Balasubramanyam and Vishwanathan Mohan},
  journal={Journal of Biosciences},
  year={2001},
  volume={26},
  pages={383-390}
}
The war against diabetes through the development of new drugs is an ongoing continuous process to counter the alarming global increase in the prevalence of diabetes and its complications, particularly in developing countries like India. Unfortunately, the speed with which our knowledge of diabetes and its effects is expanding is not matched by the availability of new drugs. Following the identification of the insulin receptor (IR), its intrinsic kinase activity and molecular cloning, many… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 79 REFERENCES

Protein-tyrosine phosphatases PTP1B and syp are modulators of insulin-stimulated translocation of GLUT4 in transfected rat adipose

H Chen, S JWertheimer, +4 authors M JQuon
  • cells; J. Biol. Chem
  • 1997
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase

A Salmeen, J NAndersen, M PMyers, N KTonks, D Barford
  • 1B; Mol. Cell
  • 2000
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…